It's in the Annual Report (page 5) released last Thursday.
I don't think 5.8c will be the top while comparing with RAP, PCK and Akili.
Just have a close look at Akili, also developing an app to target aged 8 - 12, still not received FDA approval yet, but raised US$140m over last few years. Akili does have another three apps in developments, one at advantage stage, other two at early stage. Based on Akili valuation, I guess NHL could be valued at $100m or more, as it received FDA approval and CE mark, (targeting aged 3 - 8), with two apps, TAli Train & TAli Detect, one therapy and one screening test.
All imo.
NHL Charts, page-70
-
- There are more pages in this discussion • 6,845 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TD1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.942M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 30332689 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 50416607 | 19 |
View Market Depth
| Last trade - 16.12pm 02/08/2024 (20 minute delay) ? |
| TD1 (ASX) Chart |
Day chart unavailable